Home › Non-Small Cell Lung Cancer › New Jersey › Brick
Non-Small Cell Lung Cancer clinical trials in Brick, NJ
4 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Brick (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
RecruitingPhase 3
- Ocean University Medical Center, Brick
- Jersey Shore Medical Center, Neptune City · 11 mi away
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RecruitingPhase 1/2
- John Theurer Cancer Center at JSUMC, Neptune City · 11 mi away
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
RecruitingPhase 3
- Meridian Health System, Neptune City · 11 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- CentraState Medical Center, Freehold · 16 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Brick
- Acute Myeloid Leukemia7 studies
- Breast Cancer6 studies
- Chronic Kidney Disease5 studies
- Cardiovascular Disease4 studies
- Lung Cancer4 studies
- Nausea and Vomiting4 studies
- High Blood Pressure3 studies
- Heart Failure3 studies
- Myeloproliferative Neoplasms3 studies
- Myelodysplastic Syndromes3 studies
- Obesity3 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.